The Evolving Role of GLP-1 Agonists in Ischemic Stroke Prevention in Diabetic Patients

Overview

Journal Cardiovasc Endocrinol Metab

Specialty Cardiology & Vascular Diseases

Date 2024 Aug 16

PMID 39148946

Authors

Aditi Shankar

Aditi Sharma

Chirag Buch

Robert J Chilton

Affiliations

Soon will be listed here.

References

Briyal S, Shah S, Gulati A . Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia. Neuroscience. 2014; 281:269-81. DOI: 10.1016/j.neuroscience.2014.09.064. View

Chen R, Ovbiagele B, Feng W . Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci. 2016; 351(4):380-6. PMC: 5298897. DOI: 10.1016/j.amjms.2016.01.011. View

Zhu H, Zhang Y, Shi Z, Lu D, Li T, Ding Y . The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways. Sci Rep. 2016; 6:26859. PMC: 4886514. DOI: 10.1038/srep26859. View

Marso S, Bain S, Consoli A, Eliaschewitz F, Jodar E, Leiter L . Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016; 375(19):1834-1844. DOI: 10.1056/NEJMoa1607141. View

Zhang Z, Zhang L, Jiang Q, Zhang R, Davies K, Powers C . VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000; 106(7):829-38. PMC: 517814. DOI: 10.1172/JCI9369. View

Shan Y, Tan S, Lin Y, Liao S, Zhang B, Chen X . The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke. J Neuroinflammation. 2019; 16(1):242. PMC: 6883580. DOI: 10.1186/s12974-019-1638-6. View

Basalay M, Davidson S, Gourine A, Yellon D . Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects. Basic Res Cardiol. 2018; 113(4):25. PMC: 5984640. DOI: 10.1007/s00395-018-0684-z. View

Kim S, Jeong J, Jung H, Kim B, Kim Y, Lim D . Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke. Exp Neurobiol. 2017; 26(4):227-239. PMC: 5597553. DOI: 10.5607/en.2017.26.4.227. View

Baggio L, Drucker D . Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132(6):2131-57. DOI: 10.1053/j.gastro.2007.03.054. View

10.

Wei J, Yang B, Wang R, Ye H, Wang Y, Wang L . Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis. Front Endocrinol (Lausanne). 2022; 13:1007980. PMC: 9760859. DOI: 10.3389/fendo.2022.1007980. View

11.

Rebosio C, Balbi M, Passalacqua M, Ricciarelli R, Fedele E . Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus. Biofactors. 2017; 44(2):148-157. DOI: 10.1002/biof.1406. View

12.

Kim B, Lee E, Kwon S, Park J, Kim Y, Hong K . Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial. Lancet Neurol. 2018; 17(6):509-518. DOI: 10.1016/S1474-4422(18)30128-5. View

13.

Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D . 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021; 52(7):e364-e467. DOI: 10.1161/STR.0000000000000375. View

14.

Lee J, Zipfel G, Choi D . The changing landscape of ischaemic brain injury mechanisms. Nature. 1999; 399(6738 Suppl):A7-14. DOI: 10.1038/399a007. View

15.

Marso S, Daniels G, Brown-Frandsen K, Kristensen P, Mann J, Nauck M . Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016; 375(4):311-22. PMC: 4985288. DOI: 10.1056/NEJMoa1603827. View

16.

Barkas F, Elisaf M, Milionis H . Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis. Eur J Neurol. 2019; 26(4):559-565. DOI: 10.1111/ene.13905. View

17.

Lee J, Grabb M, Zipfel G, Choi D . Brain tissue responses to ischemia. J Clin Invest. 2000; 106(6):723-31. PMC: 381398. DOI: 10.1172/JCI11003. View

18.

Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya F . GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes. 2014; 63(10):3346-58. DOI: 10.2337/db14-0302. View

19.

Malhotra K, Katsanos A, Lambadiari V, Goyal N, Palaiodimou L, Kosmidou M . GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis. J Neurol. 2020; 267(7):2117-2122. DOI: 10.1007/s00415-020-09813-4. View

20.

Chien C, Jou M, Cheng T, Yang C, Yu T, Li P . Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats. J Cereb Blood Flow Metab. 2015; 35(11):1790-803. PMC: 4635234. DOI: 10.1038/jcbfm.2015.126. View